- You can view the full Isis Pharmaceuticals Ratings Report.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
As the year winds down and the fund managers start selling stocks, Cramer will be watching for important earnings and economic data in a holiday-shortened week.
Trade-Ideas LLC identified ISIS Pharmaceuticals (ISIS) as a post-market laggard candidate
That's especially true during December when the analysts often have nice things to say to help boost their funds going into the end of the year, Cramer says.